IIb

Related by string. IIB * * Phase IIb clinical . Phase IIb trial . initiate Phase IIb . Phase IIb . Phase IIb clinical trials . modified REGENESIS Phase IIb . Phase IIb Clinical Trial . randomized Phase IIb . phase IIb clinical . Phase IIb trials . phase IIb trial . glycoprotein IIb IIIa inhibitors . Phase IIb Trial . glycoprotein IIb IIIa inhibitor . glycoprotein GP IIb IIIa *

Related by context. Frequent words. (Click for all words.) 68 IIa 62 IIIB 62 IIIa 61 IIIA 60 Dasatinib 60 hematologic toxicity 59 bleomycin 59 intra arterial 58 Factor VIIa 58 Bortezomib 57 radiolabeled 57 amphotericin B 57 liposomal formulation 57 aprepitant 57 tigecycline 57 CCX# 57 astrocytoma 56 receptor antagonists 56 T2DM 56 resectable 56 proteasome inhibitor 56 arterial thrombosis 56 BMS # 56 daunorubicin 56 lytic 56 immunohistochemical 56 figitumumab 56 mTOR inhibitor 56 TELCYTA 56 Epratuzumab 56 mycophenolate mofetil 56 Lenalidomide 56 hepatic encephalopathy 56 NYHA Class III 56 Proxinium TM 55 pheochromocytoma 55 noninferiority 55 eplerenone 55 splenic 55 vorinostat 55 lymphadenectomy 55 cangrelor 55 relapsing multiple sclerosis 55 topoisomerase 55 gonadotropin releasing hormone GnRH 55 Initiate Phase 55 interferon beta 1b 55 etravirine 55 NYHA Class II 55 proteasome inhibitors 55 K ras 55 Thrombolysis 55 Carotid 55 calcineurin inhibitors 55 monomeric 55 IV melanoma 55 squamous 54 efficacy endpoint 54 FLT3 54 mg kg dose 54 apolipoprotein B 54 cytotoxic chemotherapy 54 glatiramer acetate 54 epirubicin 54 tocilizumab 54 nonrandomized 54 Pivotal Phase 54 intravenously administered 54 pertuzumab 54 Tygacil 54 immunoreactivity 54 Pivotal Trial 54 fibrinolytic 54 luteinizing hormone releasing 54 IV metastatic melanoma 54 chemotherapeutic drug 54 Bevacizumab 54 irbesartan 54 sensory neuropathy 53 bevacizumab Avastin 53 cytochrome P# 53 DOXIL 53 angiotensin converting enzyme inhibitors 53 stenoses 53 ReoPro 53 MTHFR 53 TAXUS Stent 53 DB# [003] 53 sirolimus eluting stent 53 Aliskiren 53 refractory chronic lymphocytic 53 Thrombocytopenia 53 thymalfasin 53 #m Tc 53 stent restenosis 53 cardiac toxicity 53 pulmonary arterial hypertension PAH 53 TAXUS Liberte Stent 53 thromboembolic events 53 EBRT 53 QTc

Back to home page